After that, the FDA approved the company’s updated COVID booster shot, making it available alongside shots from Moderna and ...
Including "initial doses"—those who have received only the first dose of Pfizer ... booster. As of mid-August, by which time Delta had become the dominant strain in the U.S., all three ...
Moderna beat first-quarter expectations Thursday. The news could bolster Moderna stock which is approaching its first ...
All vaccines have at least occasional side effects. But people who say they were injured by COVID vaccines believe their cases have been ignored.
An updated COVID booster shot can be expected this fall ... XBB.1.5 Omicron strain and is expected to be effective against ...
Here’s your go-to guide with everything you need to know about COVID-19, including testing expanding to more airports, ...
Booster shots help to "remind" it of how to respond to a virus ... for certain higher-risk individuals were also recommended. In September 2023, the FDA authorized Pfizer-BioNTech's updated vaccine ...
Pfizer's huge facility in Sanford produces its first FDA-approved gene therapy, which runs $3.5 million a dose. The U.S. Food and Drug Administration has approved a gene therapy developed by ...
The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S. The ...
Ten years after dipping its toes into the gene therapy pool in a licensing deal with Spark Therapeutics, Pfizer has gained FDA approval for the acquired treatment. The U.S. regulator has endorsed ...
Friday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate to severe hemophilia B in adult patients who currently use factor IX (FIX) prophylaxis ...